Image For Activity Cover
Bempedoic Acid for LDL-Lowering: Case Challenges

This activity was planned with a goal to enable participants to learn best practices when prescribing bempedoic acid to the statin intolerant patient. This activity is part of the Bempedoic Acid: New Evidence Transforming the LDL-C Treatment Landscape grant supported by Esperion. 


Important Dates: 
Date of Release:
December 8, 2023
Term of Approval/Date of Expiration: December 8, 2024
Learner Objectives:  
Upon completion of this activity, you should be able to:

  1. Describe safety, efficacy, and long-term CV outcomes data of bempedoic acid based on clinical trial data. 

  1. Identify patients that would benefit from bempedoic acid and how to integrate this into practice.  

  1. Develop a treatment plan for the statin intolerant patient including the use of bempedoic acid. 

Educational grant support provided by: Esperion.

Erin D. Michos, MD, MHS, FACC

Availability: On-Demand
Expires on Dec 08, 2024
Cost: FREE
Credit Offered:
No Credit Offered
Android App Download IOS App Download Powered By